Josh Thole could be placed on seven-day concussion DL following collision

10 Comments

Josh Thole could be headed for the seven-day disabled list for concussions after taking a shoulder to the head on a slide from Ty Wigginton during tonight’s game against the Phillies.

The injury occurred when Freddy Galvis hit a tapper to Bobby Parnell with runners on second and third in the bottom of the eighth inning. Parnell made the throw to Thole, who tagged Wigginton to record the out, but he took a shoulder to the face while trying to spin out of the way of the slide. Thole managed to keep the ball in his glove, but he went face-down in the dirt before team trainers rushed to his side.

Thole walked off the field under his own power to warm applause from the Philadelphia crowd, but Andy McCullough of the Newark Star-Ledger reports that he kept telling trainers that he felt dizzy. He is currently being evaluated by doctors and will likely be sent back to New York for further testing.

If the Mets place Thole on the seven-day disabled list for concussions, they will likely promote either Rob Johnson or Lucas May from Triple-A Buffalo while Mike Nickeas will get the bulk of the playing time behind the plate.

Thole went 1-for-3 before exiting tonight’s game and is hitting .284/.356/.370 with a .726 OPS over his first 92 plate appearances this season.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.